Viemed Healthcare, Inc.
VMD- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001729149
No open-market purchases or sales by Viemed Healthcare, Inc. insiders were filed in the last 90 days; 166 institutions reported holding it in 13F filings for Q2 2026, worth $309.7M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +17 vs. previous quarter
- 166
- 13F valueReported value at the end of Q2 2026
- $309.7M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding VMD, Q2 2026
No superinvestor reported holding VMD at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Viemed Healthcare, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 (view filing) | Jun 25 | 1 day | Frazier WilliamChief Medical Officer | SSale | −10.0K | $11.72 | −$117.2K | −12.0%73.2K after | |
| Jun 26, 2026 (view filing) | Jun 24 | 2 days | Smokoff TimothyDirector | SSale | −20.0K | $11.50 | −$230.0K | −20.9%75.5K after | 5 lots |
| Mar 20, 2026 (view filing) | Mar 18-20 | 2 days | Moore MichaelPresident | SSale | −136.8K | $9.05 | −$1.24M | −7.9%1.59M after | 3 lots |
| Aug 14, 2025 (view filing) | Aug 13 | 1 day | Cambre JeromeVice President of Sales | SSale | −4.88K | $7.32 | −$35.7K | −5.5%84.2K after | 2 lots |
| Aug 13, 2025 (view filing) | Aug 12 | 1 day | Moore MichaelPresident | SSale | −50.1K | $7.33 | −$367.2K | −28.4%126.3K after | |
| Jul 1, 2025 (view filing) | Jun 27-30 | 4 days | Moore MichaelPresident | SSale | −181.3K | $6.92 | −$1.26M | −50.5%177.4K after | 3 lots |
| Jul 1, 2025 (view filing) | Jun 30 | 1 day | Kaushal NitinDirector | SSale | −7.05K | $6.91 | −$48.7K | −5.3%126.8K after | |
| Jun 30, 2025 (view filing) | Jun 26-27 | 4 days | Kaushal NitinDirector | SSale | −43.0K | $7.01 | −$301.0K | −25.3%126.8K after | 2 lots |
| Mar 17, 2025 (view filing) | Mar 13-14 | 4 days | Smokoff TimothyDirector | SSale | −11.9K | $7.70 | −$91.4K | −12.9%79.8K after | 5 lots |
| Nov 26, 2024 (view filing) | Nov 25-26 | 1 day | Kaushal NitinDirector | SSale | −30.0K | $8.68 | −$260.3K | −19.1%126.8K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Viemed Healthcare, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,788,307 | $54.6M | 0.00% | +165,745+3.6% | Added |
| Forager Capital Management, LLC | 2,141,184 | $24.4M | 9.18% | −684,687−24.2% | Reduced |
| Vanguard Capital Management LLC | 1,321,676 | $15.1M | 0.00% | +18,292+1.4% | Added |
| Nantahala Capital Management, LLC | 1,264,890 | $14.4M | 0.44% | +381,107+43.1% | Added |
| Goldman Sachs Group Inc | 1,222,534 | $13.9M | 0.00% | −199,100−14.0% | Reduced |
| First Eagle Investment Management, LLC | 1,070,314 | $12.2M | 0.01% | +540,657+102.1% | Added |
| Ameriprise Financial Inc | 1,006,195 | $11.5M | 0.00% | +107,876+12.0% | Added |
| Geode Capital Management, LLC | 973,744 | $11.1M | 0.00% | +194,222+24.9% | Added |
| Raffles Associates LP | 807,382 | $9.20M | 4.04% | +393,691+95.2% | Added |
| Arrowstreet Capital, Limited Partnership | 786,269 | $8.96M | 0.00% | +75,083+10.6% | Added |